EUVIMEDEUVIMED entdecken
Crossref

Hoehn and Yahr staging of Parkinson rsquo s disease in relation to neuropsychological measures

Edward Justin Modestino, AnnaMarie Reinhofer, Kenneth Blum, Chioma Amenechi, Patrick O'Toole

Frontiers in Bioscience · 2018 · 23 (7) · 1370-1379

DOI: 10.2741/4649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience, 2018. Verfasst von Edward Justin Modestino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Curry College, Milton, MA USA, edward.modestino@gmail.com. Die Arbeit wurde bisher 36-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is primarily considered to be a progressive degenerative motor disease associated with the degeneration of striatal dopamine neurons. However, increasing evidence has suggested progressive cognitive and psychiatric changes as well. Forty-six patients with PD, ranging in severity from Hoehn and Yahr (H-Y) score of 1:4, were recruited from a clinic specializing in PD. Various cognitive and neuropsychological measures were used to discover if there were indeed differences due to the progression of PD. As H-Y stage significantly increased, so did age and levodopa equivalency dose of medications, both independent of one another. Years of education had a significant negative relationship with H-Y score. Measures of general cognition divulged a significant decrease as H-Y score increased. Finally, as H-Y score increased, magical ideation decreased, and religious group social support increased. Mechanistically, the significant cognitive decline occurring with H-Y staging may be linked to a reduced dopaminergic function. Significant cognitive and neuropsychological changes are associated with the progression of PD and its possible relationship to Reward Deficiency Syndrome (RDS).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAge FactorsAgedAged, 80 and overAntiparkinson AgentsCognitionDisease ProgressionEducational StatusFemaleHumansLevodopaLinear ModelsMaleMiddle AgedNeuropsychological TestsParkinson Disease

Substanzen

Antiparkinson AgentsLevodopa

Autor:innen und Institutionen

  • Department of Psychology, Curry College, Milton, MA USA, edward.modestino@gmail.com.
  • Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
  • Department of Psychiatry, McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA.

Zitieren

APA

Modestino, E. J., Reinhofer, A., Blum, K., Amenechi, C., & O'Toole, P. (2018). Hoehn and Yahr staging of Parkinson rsquo s disease in relation to neuropsychological measures. Frontiers in Bioscience, 23(7), 1370-1379. https://doi.org/10.2741/4649

Vancouver

Modestino EJ, Reinhofer A, Blum K, Amenechi C, O'Toole P. Hoehn and Yahr staging of Parkinson rsquo s disease in relation to neuropsychological measures. Frontiers in Bioscience. 2018;23(7):1370-1379. doi:10.2741/4649

BibTeX
@article{Modestino2018,
  author = {Modestino, Edward Justin and Reinhofer, AnnaMarie and Blum, Kenneth and Amenechi, Chioma and O'Toole, Patrick},
  title = {Hoehn and Yahr staging of Parkinson rsquo s disease in relation to neuropsychological measures},
  journal = {Frontiers in Bioscience},
  year = {2018},
  volume = {23},
  number = {7},
  pages = {1370--1379},
  doi = {10.2741/4649}
}
Kostenlos starten →